preterm birth
The report recommended against the use of markers including fetal fibronectin and Sera Prognostics' PreTRM test due to low positive predictive value.
New AACC Guidance Advises Against Using Tests to Predict Premature Birth
The guidance cites evidence that premature birth tests don't improve outcomes for patients at risk of premature delivery or their babies.
The company launched in November a survey-based test for screening patients for preterm birth risk that it plans to pair with a mass spectrometry-based assay.
Sera Prognostics, Anthem Partner on Preterm Delivery Risk Test to Improve Outcomes, Reduce Costs
Premium
The companies have launched a 5,600 subject study to look at whether the test is able to improve outcomes and reduce costs among Anthem beneficiaries.
Sera Prognostics, Anthem Partner on Preterm Birth Study
The study aims to evaluate how pairing Sera's PreTRMÂ test with clinical interventions may mitigate preterm birth risk, improve neonatal outcomes, and reduce healthcare costs.